ANN ARBOR, Mich., March 28, 2011 /PRNewswire/ — Adeona
Pharmaceuticals, Inc. (Amex:
AEN), a developer of innovative medicines for serious central
nervous system diseases, announced today that it will hold its 2010
year end investor conference call on Thursday, March 31, 2011, at
4:30pm EDT. James S. Kuo, M.D., M.B.A., Adeona’s Chief Executive
Officer, will host the call.
Interested parties should call toll free 1-800-860-2442
(U.S.) or 1-866-605-3852 (Canada), or from outside North America +1
412-858-4600, fifteen minutes before the start of the call to
register and identify themselves as registrants of the ‘Adeona’
Conference Call. Any registered caller on the toll free line may
ask to be placed in the queue for the Question & Answer
session. The call will be simulcast on the web at http://www.videonewswire.com/event.asp?id=77882.
If you are unable to participate during the live call, the webcast
will be available for replay at www.adeonapharma.com for 30
days after the call.
About Adeona Pharmaceuticals, Inc.
Adeona is a pharmaceutical company developing innovative
medicines for the treatment of serious central nervous system
diseases. The Company’s strategy is to license product candidates
that have demonstrated a certain level of clinical efficacy and
develop them to a stage that results in a significant commercial
collaboration. Currently, Adeona is developing the following
product candidates: a prescription medical food for Alzheimer’s
disease, and drugs for multiple sclerosis, fibromyalgia,
age-related macular degeneration and rheumatoid arthritis. For more
information, please visit Adeona’s website at www.adeonapharma.com.